Filing Type and Date: Form 8-K current report filed August 6, 2026, reporting events as of August 6, 2026 Company Information: DENTSPLY SIRONA Inc., a Delaware corporation in the dental equipment and supplies industry (SIC 3843), headquartered in Charlotte, North Carolina, with common stock trading under ticker symbol XRAY on The Nasdaq Stock Market LLC Item Information Disclosed: The filing…

Our analysis rates this filing NEUTRAL. DENTSPLY SIRONA presents a balanced but cautious picture. The company faces a genuine business challenge with declining revenues that persists despite management's turnaround efforts, warranting concern. However, this is offset by meaningful operational…

Concern level: ELEVATED (4.2/10). Key factors: Revenue declined 4.1% YoY to $898M in Q2 2026 - persistent top-line pressure despite turnaround initiatives; Company has not demonstrated growth acceleration despite 'Return-to-Growth Action Plan' - stabilization narrative rather than recovery; Management tone is cautiously optimistic but measured - emphasizes execution discipline rather than…

Notable risk changes: Q2 2026 revenue declined 4.1% YoY to $898M (from $936M in Q2 2025) - continued top-line pressure despite management's 'Return-to-Growth Action Plan'; Swing from net loss of $45M in Q2 2025 to net income of $37M in Q2 2026 - improvement driven by gross margin expansion (52.4% to 54.9%) rather than volume growth; Company reiterates 2026 full-year outlook despite Q2 revenue miss - suggests…

Not disclosed - earnings surprise data not provided in this filing.

The model predicts XRAY will outperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.